Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667865 | SCV000792376 | uncertain significance | Fanconi anemia complementation group A | 2017-06-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001243928 | SCV001417118 | likely benign | Fanconi anemia | 2023-12-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004975281 | SCV005583383 | uncertain significance | Inborn genetic diseases | 2024-12-06 | criteria provided, single submitter | clinical testing | The p.R670C variant (also known as c.2008C>T), located in coding exon 22 of the FANCA gene, results from a C to T substitution at nucleotide position 2008. The arginine at codon 670 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |
Fulgent Genetics, |
RCV000667865 | SCV005646583 | uncertain significance | Fanconi anemia complementation group A | 2024-01-10 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000120922 | SCV000085090 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Natera, |
RCV001243928 | SCV002092648 | uncertain significance | Fanconi anemia | 2020-04-28 | no assertion criteria provided | clinical testing |